These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20975074)

  • 1. What role should cilengitide have in the treatment of glioblastoma?
    Chamberlain MC
    J Clin Oncol; 2010 Nov; 28(33):e695; author reply e696-7. PubMed ID: 20975074
    [No Abstract]   [Full Text] [Related]  

  • 2. Cilengitide in glioblastoma: when did it fail?
    Chinot OL
    Lancet Oncol; 2014 Sep; 15(10):1044-5. PubMed ID: 25163907
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results.
    Scaringi C; Minniti G; Caporello P; Enrici RM
    Anticancer Res; 2012 Oct; 32(10):4213-23. PubMed ID: 23060541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does cilengitide deserve another chance?
    Tucci M; Stucci S; Silvestris F
    Lancet Oncol; 2014 Dec; 15(13):e584-e585. PubMed ID: 25456376
    [No Abstract]   [Full Text] [Related]  

  • 5. Does cilengitide deserve another chance?-Authors' reply.
    Stupp R; Picard M; Weller M
    Lancet Oncol; 2014 Dec; 15(13):e585-e586. PubMed ID: 25456377
    [No Abstract]   [Full Text] [Related]  

  • 6. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cilengitide: a new weapon against glioblastoma?].
    Tumori; 2008; 94(5):suppl 1-2. PubMed ID: 19112962
    [No Abstract]   [Full Text] [Related]  

  • 8. Temozolomide for malignant brain tumours.
    Batchelor T
    Lancet; 2000 Apr; 355(9210):1115-6. PubMed ID: 10791369
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens: is the survival really so impressive?: in regard to Combs et al. (Int J Radiat Oncol Biol Phys 2008;71:999-1005).
    Jalali R
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1622; author reply 1622-3. PubMed ID: 19028293
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma.
    Stupp R; Hegi ME; Neyns B; Goldbrunner R; Schlegel U; Clement PM; Grabenbauer GG; Ochsenbein AF; Simon M; Dietrich PY; Pietsch T; Hicking C; Tonn JC; Diserens AC; Pica A; Hermisson M; Krueger S; Picard M; Weller M
    J Clin Oncol; 2010 Jun; 28(16):2712-8. PubMed ID: 20439646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic radiotherapy for glioblastoma in the elderly.
    Tartarone A; Ardito R; Romano C
    N Engl J Med; 2007 Jul; 357(2):196; author reply 196. PubMed ID: 17626310
    [No Abstract]   [Full Text] [Related]  

  • 13. End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma.
    Mason WP
    Neuro Oncol; 2015 May; 17(5):634-5. PubMed ID: 25681307
    [No Abstract]   [Full Text] [Related]  

  • 14. Glioblastoma therapy in the elderly: one age does not fit all.
    Nghiemphu PL; Cloughesy T
    Lancet Oncol; 2012 Sep; 13(9):857-8. PubMed ID: 22877850
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).
    Linz U
    Cancer; 2010 Apr; 116(8):1844-6. PubMed ID: 20151424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.
    Seystahl K; Gramatzki D; Roth P; Weller M
    Expert Opin Pharmacother; 2016 Jun; 17(9):1259-70. PubMed ID: 27052640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for glioblastoma: is costly better?
    Linz U
    Cancer; 2008 Nov; 113(10):2617-22. PubMed ID: 18833584
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of brain tumors.
    Ashby L; LaRocca R; Ryken T
    N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938013
    [No Abstract]   [Full Text] [Related]  

  • 19. Current therapies for glioblastoma.
    Yung WK
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):572-3. PubMed ID: 16163238
    [No Abstract]   [Full Text] [Related]  

  • 20. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
    Hamilton DA
    Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.